Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -6.02% | 384.21 | 0.0% | $5285.71m | |
| BNTX | BioNTech SE | -9.96% | 276.52 | 0.0% | $899.27m | |
| NVAX | Novavax, Inc. | -11.34% | 204.83 | 79.4% | $857.11m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -5.26% | 7.93 | 0.7% | $554.34m | |
| AMGN | Amgen, Inc. | -0.39% | 212.27 | 1.4% | $540.36m | |
| GILD | Gilead Sciences, Inc. | -0.63% | 69.97 | 1.0% | $446.95m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.27% | 605.00 | 2.7% | $428.21m | |
| ILMN | Illumina, Inc. | -3.61% | 410.20 | 3.5% | $346.87m | |
| BIIB | Biogen, Inc. | -0.67% | 284.71 | 1.7% | $303.41m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.99% | 181.60 | 1.9% | $247.39m | |
| ISEE | IVERIC bio, Inc. | -10.97% | 15.58 | 0.0% | $187.66m | |
| LIFE | aTyr Pharma, Inc. | -1.41% | 9.76 | 2.1% | $149.96m | |
| BGNE | BeiGene Ltd. | -3.55% | 363.80 | 1.3% | $141.01m | |
| TECH | Bio-Techne Corp. | -4.42% | 488.87 | 4.5% | $131.91m | |
| KDMN | Kadmon Holdings, Inc. | -0.45% | 8.80 | 0.8% | $129.86m |
Company Profile
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the following segments: Proprietary Products and Distribution. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.